Skip to main content
. 2017 Aug 21;8:985. doi: 10.3389/fimmu.2017.00985

Figure 1.

Figure 1

Effect of human catestatin (hCTS) treatment (1.5 mg/kg/day, i.r. 7 days) on weight loss and macroscopic score during colitis reactivation in quiescent colitic mice. The 7-day hCTS treatment did not improve weight loss observed in chronic quiescence colitic mice (A). However, during sacrifice hCTS treatment significantly improved stool consistency (B), rectal bleeding (C), and macroscopic score (D) in colitic mice. The macroscopic score was determined on the day of sacrifice considering fecal consistency, hyperplasia, and rectal bleeding. AU, arbitrary units, aP < 0.05 compared to the Control [No dextran sulfate sodium (DSS)/No hCTS] group; bP < 0.05 compared to the hCTS (No DSS) group; cP < 0.05 compared to the DSS (No hCTS) group; Bonferroni, one-way ANOVA. Control (n = 5), hCTS (n = 5), 4% DSS (n = 10), 4% DSS + hCTS (n = 12).